Your browser doesn't support javascript.
loading
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview.
Viola, P; Testa, V; Ferro Desideri, L; Di Cello, L; Rutigliani, C; Vagge, A; Nicolò, M; Cian, R; Traverso, C E.
Afiliação
  • Viola P; Ospedale San Bortolo, Vicenza, Italy.
  • Testa V; Ospedale San Bortolo, Vicenza, Italy.
  • Ferro Desideri L; Eye Clinic, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Di Cello L; University Eye Clinic of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. lorenzoferrodes@gmail.com.
  • Rutigliani C; Eye Clinic, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Vagge A; University Eye Clinic of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Nicolò M; IRCCS Ospedale San Raffaele, University Vita-Salute, Milan, Italy.
  • Cian R; Eye Clinic, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Traverso CE; University Eye Clinic of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Drugs Today (Barc) ; 57(11): 689-697, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34821882

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Ranibizumab Limite: Humans Idioma: En Revista: Drugs Today (Barc) Assunto da revista: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Ranibizumab Limite: Humans Idioma: En Revista: Drugs Today (Barc) Assunto da revista: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália